Stop by our booth at the Society for Neuroscience 2025 Annual Meeting for an inside look at our iPSC-based platforms — including dopaminergic neurons, motor neurons, microglia and neural mixes — and how they’re built for scalability, reproducibility and translational insight across neurodegenerative, neuroinflammatory and psychiatric disease areas.
Whether you’re advancing early-stage discovery, modeling disease mechanisms or improving CNS safety assessments, it’s time to accelerate your next breakthrough.
A Human iPSC-Based Platform for Functional and Molecular Evaluation of ALS Therapeutics
Targeting TDP-43 Pathology
Speaker: Shushant Jain, Ph.D., Director Discovery Technology
Presentation Time: Tuesday, November 18, 2025, 2:45 PM - 3:00 PM
Location/Room: SDCC Rm 11
Session Type: Nanosymposium
Session Number: NANO039
Session Title: ALS: Human Genetics, Cellular Mechanisms, and Potential Treatments
Evaluation of human induced pluripotent stem cell (hiPSC) derived tri-culture as in vitro model for Alzheimer's Disease
Development of iPSC based Parkinson's disease model for drug discovery